BP4 S.r.l. disposes of 40,000 MLSS shares; holdings 9.20M

Rhea-AI Filing Summary

BP4 S.r.l., listed as a Director and 10% Owner, reported insider sales of common stock in MILESTONE SCIENTIFIC INC. (MLSS).

The filing shows two sales: 10,000 shares sold on 10/07/2025 at $0.45 and 30,000 shares sold on 10/08/2025 at $0.465, a total of 40,000 shares. Following the transactions, the reporting person reported beneficial ownership of 9,195,384 shares.

The form is signed by /s/ Dr. Pedro Palau, Liquidator on 10/09/2025. The transactions are reported as direct ownership changes and involve common stock only.

Positive

• None.

Negative

• Reported insider sales totaled 40,000 shares, reducing beneficial ownership.
• Holdings declined to 9,195,384 shares after the transactions.

Insights

Insider Transactions Analyst

Officer-listed entity sold 40,000 MLSS shares across two days, lowering holdings to 9,195,384.

The filings record two sales: $0.45 for 10,000 shares on 10/07/2025 and $0.465 for 30,000 shares on 10/08/2025, both reported as direct disposals. The reporting person is identified as BP4 S.r.l. with the role boxes indicating Director and 10% Owner.

These transactions reduced the reported beneficial stake to 9,195,384 shares. Monitor subsequent Form 4 filings within the next weeks for additional sales or changes in ownership reported by the same reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BP4 S.r.l.

(Last) (First) (Middle)

CORSO VENEZIA 44

(Street)

MILAN L6 20121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MILESTONE SCIENTIFIC INC. [ MLSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $0.001	10/07/2025		S		10,000	D	$0.45	9,225,384	D
Common Stock, Par Value $0.001	10/08/2025		S		30,000	D	$0.465	9,195,384	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Dr. Pedro Palau, Liquidator	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for MLSS?

The filing reports sales of 10,000 shares on 10/07/2025 at $0.45 and 30,000 shares on 10/08/2025 at $0.465.

Who filed the Form 4 for MLSS?

The reporting person is listed as BP4 S.r.l., marked as a Director and 10% Owner, signed by Dr. Pedro Palau, Liquidator on 10/09/2025.

How many MLSS shares does the reporting person own after the transactions?

The filing shows beneficial ownership of 9,195,384 shares following the reported sales.

Were the reported transactions direct or indirect?

Both disposals are reported as direct (ownership form marked as D) in the non-derivative securities table.

Are there any derivative securities reported in this Form 4?

No. Table II for derivative securities contains no reported transactions or holdings.